{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:42:29Z","timestamp":1773081749009,"version":"3.50.1"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4927,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>OBJECTIVES <\/jats:bold> The physiological role Of growth hormone in adult life has recently attracted increased Interest. We have studied the clinical effects and the effects on body composition of prolonged replacement with biosynthetic human GH In a large number of hypopituitary adults. DESIGN A randomized double blind placebo controlled trial for 6 months followed by an open trial of GH treatment for 12 months. GH dally dose was 0\u00b704 (0\u00b702\u20100\u00b705) IU\/kg s.c.<\/jats:p><jats:p><jats:bold>PATIENTS <\/jats:bold> Forty GH deficient hypopituitary patients (19 M, 21 F; aged 19\u201367 years) on conventional replacement therapy were studied.<\/jats:p><jats:p><jats:bold>MEASUREMENTS <\/jats:bold> Serum insulin like growth factor I (IGF\u2010I), skinfold thickness, total body potassium, total body water (TBW), exercise tolerance and muscle strength, and well\u2010being.<\/jats:p><jats:p><jats:bold>RESULTS <\/jats:bold> During the 6\u2010month double blind phase, two GH treated patients withdrew because of adverse events. Lean body mass (LBM) increased and percentage body fat (%BF) decreased on GH but not on placebo (P) (LBM: (GH: from 48\u00b75 \u00b1 9\u00b76 to 49\u00b76 \u00b1 9\u00b75kg; P: from 50\u00b79 \u00b1 9\u00b72 to 50\u00b71 \u00b1 9\u00b70kg, P &lt; 0\u00b705 GH <jats:italic>vs<\/jats:italic> P) and TBW (OH: from 34\u00b77 \u00b1 11\u00b74 to 34\u00b72 \u00b1 10\u00b77; P: from 37\u00b74 \u00b1 7\u00b76 to 38\u00b77 \u00b1 8\u00b71, P &lt; 0\u00b705 GH <jats:italic>vs<\/jats:italic> P). TBW Increased on GH (P &lt; 0\u00b701) but not on P. No change was observed In waist\u2010to\u2010hip ratio or in muscle strength. During longer\u2010term follow\u2010up combining the double blind and open phase components of the study, 34, 27 and 11 patients received OH for 6,12 and 18 months respectively. Patients dropped out because of adverse events or lack of perceived benefit. Skinfold thicknesses decreased significantly at 6 and 12 months and the waist circumference at 6 months. Waist\u2010to\u2010hip ratio decreased significantly on OH at 12 months. LBM increased on GH treatment from 49\u00b76 \u00b1 9\u00b71 to 51\u00b76 \u00b1 9\u00b74kg (P &lt; 0\u00b70006), 51\u00b79 \u00b1 8\u00b79kg (P &lt; 0\u00b707) and 53\u00b71 \u00b1 10\u00b75 kg (P &lt; 0\u00b70001) at 6, 12 and 18 months respectively. Percentage body fat decreased on GH from 37\u00b72 \u00b1 10\u00b77 to 34\u00b77 \u00b1 10\u00b71 (P &lt; 0\u00b7005), 35\u00b71 \u00b1 12\u00b78 (NS) and 34\u00b75 \u00b1 86 (P &lt; 0\u00b704) at 6, 12 and 18 months respectively. TBW also increased at 6 and 12 months of GH treatment. Exercise time increased significantly at 6, 12 and 18 months of GH treatment. Muscle strength in selected muscle groups Increased significantly at 6, 12 or 18 months of GH treatment. Randomization resulted in the placebo group having a greater GHQ score (higher morbidity) than the OH group before therapy. Over the controlled phase, GHQ scores improved on placebo but not on OH and CPRS score was unchanged in either group. In the open phase, the GHQ score did not change on GH therapy but CPRS score improved at 6 and 12 months.<\/jats:p><jats:p><jats:bold>CONCLUSIONS <\/jats:bold> Growth hormone replacement therapy in adults for 6 months increased lean body mass, total body water and exercise tolerance, and decreased body fat. Growth hormone replacement for longer than 6 months maintains the advantageous effects seen in shorter\u2010term studies and may have additional effects on body fat distribution, muscle strength and psychological well\u2010being.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1995.tb02601.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T10:33:46Z","timestamp":1205750026000},"page":"73-84","source":"Crossref","is-referenced-by-count":92,"title":["Replacement treatment with biosynthetic human growth hormone in growth hormone\u2010deficient hypopituitary adults*"],"prefix":"10.1111","volume":"42","author":[{"given":"Salem A.","family":"Beshyah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Freemantie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjit","family":"Shahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Anyaoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Merson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Foale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond G.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1978.tb02357.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.2.309"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-4-361"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/ajcn\/55.5.918","article-title":"Body composition in growth hormone deficient adults","volume":"55","author":"Binnerts A.","year":"1992","journal-title":"American Journal of Clinical Nutrition"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.25.6.512"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.32.4.742"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000182734"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02347.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1991.70.2.688"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","article-title":"Growth hormone treatment in growth hormone deficient adults. II Effects on exercise performance","volume":"70","author":"Cuneo R.C.","year":"1991","journal-title":"Journal of Applied Physiology"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90145-E"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0810587"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.3.833"},{"key":"e_1_2_1_15_1","first-page":"185","article-title":"Physical and psychological capabilities during substitutuin therapy with recombinant growth treatment in adults with growth hormone deficiency","volume":"123","author":"Degerblad M.","year":"1990","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0520283"},{"key":"e_1_2_1_17_1","volume-title":"Manual of the General Health Questionnaire","author":"Goldberg D.P.","year":"1978"},{"key":"e_1_2_1_18_1","first-page":"51","article-title":"Measurement of free form of insulin like growth factor 1 in human plasma","volume":"1","author":"Hizuka N.","year":"1991","journal-title":"Growth Regulation"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000182188"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(90)90065-K"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92328-3"},{"key":"e_1_2_1_22_1","first-page":"449","article-title":"Long\u2010term gorwth hormone treatment in growth hormone deficient adults","volume":"125","author":"Jorgensen J.O.L.","year":"1991","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/44.3.417"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/014107689408700805","article-title":"Psychiatric morbidity in adults with hypopituitarism","volume":"87","author":"Lynch S.","year":"1994","journal-title":"Journal of the Royal Society of Medicine"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000181584"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00974.x"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02452.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1985.tb04195.x"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007053230101"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110164"},{"key":"e_1_2_1_31_1","first-page":"232","article-title":"Changes in body composition in adult growth hormone deficient patients withdrawn from long term treatment: Comparison of total body potassium and bioelectrical impedance measurements","volume":"132","author":"Russell\u2010Jones D.L.","year":"1992","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb00327.x"},{"key":"e_1_2_1_33_1","first-page":"41","article-title":"Quadriceps strength before and during growth hormone treatment in hypopituitary adults: relationship to changes in lean body mass and IGF\u2010I","volume":"1","author":"Rutherford O.M.","year":"1994","journal-title":"Endocrinology and Metabolism"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912283212605"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000181583","article-title":"Replacement therapy in hypothalamopituitary insufficiency after childhood: Management in the adult","volume":"33","author":"S\u00f6nksen P.H.","year":"1990","journal-title":"Hormone Research"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02520540"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/000456328602300406"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302306"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb00307.x"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02901.x"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-79-19454"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.46.11.1006"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.5.384"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1995.tb02601.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1995.tb02601.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:04:22Z","timestamp":1698300262000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1995.tb02601.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1111\/j.1365-2265.1995.tb02601.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02601.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}